Ipca Laboratories’ wholly owned subsidiary -- Ipca Pharmaceuticals Inc., USA has acquired 80% share capital of Bayshore Pharmaceuticals LLC (Bayshore), a New Jersey liability company on October 2, 2018, for cash of $10.286 million. The acquired company belongs to Sales and Marketing of FDA approved Generics Drug Products in the United States of America.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
